BioSherpa™ Specimen Transport System (STS)
BioSherpa™(STS) is a first-in-class biofilm-reducing diagnostic agent that facilitates microbiologic diagnosis even in patients who are being treated with antibiotics.
Standard Collection of Biological Samples
If a sample taken from a patient is not immediately cultured on the petri dish, the infectious organisms can die before the sample reaches the lab. As a result causative pathogens can easily be missed.
Learn more about the problem with conventional sample collection…
BioSherpa™ Specimen Transport System (STS)
BioSherpa™ STS dramatically increases the chance that a culture will identify a causative pathogen, even when the patient is on antibiotics that traditionally sterilize the sample.
Founders
BioSherpa™ STS is a game changer.
Through the use of BioSherpa™ STS, we can isolate pathogens that typically die or hide in the mass of commensal organisms.
Learn more about BioSherpa STS’s examples of superior microbiological results.
Watch BioSherpa™ STS in action.
BioSherpa™ STS can increase potential revenue
by providing accurate culture results. Accurate results lead to the use of specific codes which result in higher reimbursement rates and to the streamlining of antibiotic therapy which typically will reduce the cost to hospitals.
Learn more about how BioSherpa STS can increase potential revenue…
BioSherpa™ STS value proposition is threefold:
Supports Sepsis Protocols by delivering reliable, accurate culture results even in antibiotic treated patients.
